High Tower Advisors, LLC Becton Dickinson & CO Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, High Tower Advisors, LLC holds 363,192 shares of BDX stock, worth $82.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

363,192

Previous 373,514 2.76%

Holding current value

$82.5 Million

Previous $92.4 Million 8.16%

% of portfolio

0.13%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$225.07 - $246.17 $2.32 Million - $2.54 Million	-10,322 Reduced 2.76%	363,192 $84.9 Million
Q1 2024 May 06, 2024	SELL	$233.45 - $247.73 $1.34 Million - $1.42 Million	-5,729 Reduced 1.51%	373,514 $92.4 Million
Q4 2023 Feb 12, 2024	SELL	$232.24 - $267.23 $8.97 Million - $10.3 Million	-38,605 Reduced 9.24%	379,243 $92.5 Million
Q3 2023 Nov 08, 2023	BUY	$254.9 - $283.59 $1.52 Million - $1.69 Million	5,963 Added 1.45%	417,848 $108 Million
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $10.5 Million - $11.7 Million	44,032 Added 11.97%	411,885 $109 Million
Q1 2023 May 11, 2023	SELL	$229.71 - $259.35 $958,120 - $1.08 Million	-4,171 Reduced 1.12%	367,853 $91.1 Million
Q4 2022 Feb 08, 2023	BUY	$218.29 - $256.91 $912,233 - $1.07 Million	4,179 Added 1.14%	372,024 $94.6 Million
Q3 2022 Nov 09, 2022	SELL	$51.03 - $264.23 $140,128 - $725,575	-2,746 Reduced 0.74%	367,845 $82 Million
Q2 2022 Aug 10, 2022	SELL	$234.74 - $275.42 $486,616 - $570,945	-2,073 Reduced 0.56%	370,591 $91.3 Million
Q1 2022 May 12, 2022	BUY	$243.64 - $270.48 $3.21 Million - $3.56 Million	13,165 Added 3.66%	372,664 $99.2 Million
Q4 2021 Feb 10, 2022	BUY	$230.08 - $250.94 $38.3 Million - $41.8 Million	166,642 Added 86.41%	359,499 $90.4 Million
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $33.8 Million - $37.2 Million	145,222 Added 304.86%	192,857 $47.4 Million
Q2 2021 Aug 06, 2021	SELL	$232.65 - $254.58 $184,026 - $201,372	-791 Reduced 1.63%	47,635 $11.6 Million
Q1 2021 May 10, 2021	SELL	$232.09 - $256.88 $2.18 Million - $2.42 Million	-9,413 Reduced 16.27%	48,426 $11.8 Million
Q4 2020 Feb 10, 2021	BUY	$221.92 - $245.94 $2.35 Million - $2.61 Million	10,609 Added 22.46%	57,839 $14.5 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $540,503 - $693,283	2,505 Added 5.6%	47,230 $11 Million
Q2 2020 Aug 10, 2020	SELL	$219.9 - $263.41 $55,194 - $66,115	-251 Reduced 0.56%	44,725 $10.7 Million
Q1 2020 May 21, 2020	BUY	$195.69 - $279.01 $8.8 Million - $12.5 Million	44,976 New	44,976 $10.3 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $10.4 Million - $11.7 Million	-43,919 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$230.58 - $256.08 $2.76 Million - $3.06 Million	-11,958 Reduced 21.4%	43,919 $11.1 Million
Q2 2019 Aug 13, 2019	BUY	$217.4 - $246.08 $297,620 - $336,883	1,369 Added 2.51%	55,877 $14.1 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $344,927 - $415,436	1,674 Added 3.17%	54,508 $13.6 Million
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $828,132 - $1.04 Million	4,045 Added 8.29%	52,834 $11.9 Million
Q3 2018 Nov 09, 2018	SELL	$233.07 - $256.0 $765,634 - $840,960	-3,285 Reduced 6.31%	48,789 $12.7 Million
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $99,263 - $111,546	477 Added 0.92%	52,074 $12.5 Million
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $17,875 - $20,903	-87 Reduced 0.17%	51,597 $11.2 Million
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $425,439 - $501,162	-2,251 Reduced 4.17%	51,684 $11.1 Million
Q3 2017 Nov 14, 2017	SELL	$186.89 - $198.9 $63,729 - $67,824	-341 Reduced 0.63%	53,935 $10.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	54,276	54,276 $10.6 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

254M

Call Options Held

586K

Put Options Held

656K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Becton Dickinson & CO Transaction History